TY - JOUR
T1 - 3D-chiral (2.5) atom-based TOMOCOMD-CARDD descriptors
T2 - Theory and QSAR applications to central chirality codification
AU - Marrero-Ponce, Yovani
AU - Castillo-Garit, Juan Alberto
AU - Castro, Eduardo A.
AU - Torrens, Francisco
AU - Rotondo, Richard
N1 - Funding Information:
Acknowledgements One of the authors (M-P. Y) thanks the program ‘Estades Temporals per a Investig-adors Convidats’ for a fellowship to work at Valencia University (2008). M-P. Y also thanks support from Spanish MEC (Project Reference: SAF2006-04698). F. T. acknowledges financial support from the Spanish MEC DGI (Project No. CTQ2004-07768-C02-01/BQU) and Generalitat Valenciana (DGEUI INF01-051 and INFRA03-047, and OCYT GRUPOS03-173. Finally, but not less important, M-P. Y thanks are given to the projects entitle “Strengthening postgraduate education and research in Pharmaceutical Sciences”. This project is funded by the Flemish Interuniversity Council (VLIR) of Belgium.
PY - 2008/10
Y1 - 2008/10
N2 - The history of the use of chiral descriptors in Quantitative structure-activity relationships (QSAR) studies is described, with a particular emphasis on several series of novel chirality descriptors that have been introduced in this field. Specifically, chiral topological indices that circumvent the inability of conventional (chiral insensitive) topological molecular descriptors are reviewed. These modified descriptors were applied to several well-know data sets in order to validate each one of them. Particularly, Cramer's steroid data set has become a benchmark for the assessment of novel QSAR methods. This data set has been used by several researches using 3D-QSAR approaches such as Comparative Molecular Field Analysis (CoMFA), Comparative Molecular Similarity Indices Analysis (CoMSIA), Molecular Quantum Similarity Measures (MQSM), 3D-chiral (2.5) TOMOCOMD-CARDD descriptors, Topological Quantum Similarity Indices (TQSI), similarity matrixes, Comparative Molecular Moment Analysis (CoMMA), E-state, Mapping Property Distributions of Molecular Surfaces (MAP), EVA and so on. For that reason, it was selected for the shake of comparability by us. An extensive comparison between all these approaches was updated. In addition, to evaluate the effectiveness of this novel approach in drug design we have modelled the angiotensin-converting enzyme inhibitory activity of perindoprilate's σ-stereoisomers combinatorial library as well as to codify information related to pharmacological property highly dependent on molecular symmetry of a set of seven pairs of chiral N-alkylated 3-(3-hydroxyphenyl)-piperidines that bind σ-receptors. The validation of this method was achieved by comparison with previous reports applied to the same data sets. The non-stochastic and stochastic 3D-chiral (2.5) bilinear indices appear to provide a very interesting alternative to other more common 3D-QSAR descriptors.
AB - The history of the use of chiral descriptors in Quantitative structure-activity relationships (QSAR) studies is described, with a particular emphasis on several series of novel chirality descriptors that have been introduced in this field. Specifically, chiral topological indices that circumvent the inability of conventional (chiral insensitive) topological molecular descriptors are reviewed. These modified descriptors were applied to several well-know data sets in order to validate each one of them. Particularly, Cramer's steroid data set has become a benchmark for the assessment of novel QSAR methods. This data set has been used by several researches using 3D-QSAR approaches such as Comparative Molecular Field Analysis (CoMFA), Comparative Molecular Similarity Indices Analysis (CoMSIA), Molecular Quantum Similarity Measures (MQSM), 3D-chiral (2.5) TOMOCOMD-CARDD descriptors, Topological Quantum Similarity Indices (TQSI), similarity matrixes, Comparative Molecular Moment Analysis (CoMMA), E-state, Mapping Property Distributions of Molecular Surfaces (MAP), EVA and so on. For that reason, it was selected for the shake of comparability by us. An extensive comparison between all these approaches was updated. In addition, to evaluate the effectiveness of this novel approach in drug design we have modelled the angiotensin-converting enzyme inhibitory activity of perindoprilate's σ-stereoisomers combinatorial library as well as to codify information related to pharmacological property highly dependent on molecular symmetry of a set of seven pairs of chiral N-alkylated 3-(3-hydroxyphenyl)-piperidines that bind σ-receptors. The validation of this method was achieved by comparison with previous reports applied to the same data sets. The non-stochastic and stochastic 3D-chiral (2.5) bilinear indices appear to provide a very interesting alternative to other more common 3D-QSAR descriptors.
KW - 3D-QSAR
KW - Angiotesin-converting enzyme inhibitors
KW - Binding affinity of steroids
KW - Non-Stochastic and Stochastic 3D-chiral (2.5) atom-based TOMOCOMD-CARDD descriptors
KW - σ-Receptor antagonists
UR - http://www.scopus.com/inward/record.url?scp=51849146091&partnerID=8YFLogxK
U2 - 10.1007/s10910-008-9386-3
DO - 10.1007/s10910-008-9386-3
M3 - Artículo
AN - SCOPUS:51849146091
SN - 0259-9791
VL - 44
SP - 755
EP - 786
JO - Journal of Mathematical Chemistry
JF - Journal of Mathematical Chemistry
IS - 3
ER -